TY - JOUR
T1 - Pico-Salax versus polyethylene glycol for bowel cleanout before colonoscopy in children
T2 - A randomized controlled trial
AU - Turner, D.
AU - Benchimol, E. I.
AU - Dunn, H.
AU - Griffiths, A. M.
AU - Frost, K.
AU - Scaini, V.
AU - Avolio, J.
AU - Ling, S. C.
PY - 2009
Y1 - 2009
N2 - Background and study aims: Comparison of bowel preparation for colonoscopy in children with either Pico-Salax (sodium picosulphate with magnesium citrate) or polyethylene glycol with electrolyte solution (PEG-ELS). Patients and methods: In this investigator-blinded, randomized controlled trial, 83 children (12.5 ±3.1 years) requiring elective colonoscopy at a referral hospital were randomly allocated to Pico-Salax (n=43) or PEG-ELS (n=40), and an intention-to treat analysis was applied. Pico-Salax was administered in two doses, one the evening before and one on the morning of the procedure. PEG-ELS was administered over 4 hours. Efficacy was scored using the Ottawa scale and other constructs. Tolerability and toxicity were measured by patient and nursing questionnaires and serum biochemistry. Results: 35 of Pico-Salax patients (81%) were satisfied or very satisfied with the cleanout, compared with 19 (48%) in the PEG-ELS group (P=0.001). No differences were found in bowel cleanout effectiveness, as judged by the Ottawa score (P=0.24), completion rates (P=0.69), colonoscopy duration (P=0.59), need for enemas (P=0.25), or physicians global impression (P=0.7). Except for one case of mild dehydration in the Pico-Salax group, no clinically significant adverse events were recorded. Serum biochemistry results were similar between groups except for more hypermagnesemia associated with Pico-Salax and hypokalemia with PEG-ELS; neither was clinically significant. Conclusion: Children tolerate Pico-Salax better than PEG-ELS for bowel cleanout before colonoscopy. This study did not demonstrate superiority of effectiveness or safety for either regimen.
AB - Background and study aims: Comparison of bowel preparation for colonoscopy in children with either Pico-Salax (sodium picosulphate with magnesium citrate) or polyethylene glycol with electrolyte solution (PEG-ELS). Patients and methods: In this investigator-blinded, randomized controlled trial, 83 children (12.5 ±3.1 years) requiring elective colonoscopy at a referral hospital were randomly allocated to Pico-Salax (n=43) or PEG-ELS (n=40), and an intention-to treat analysis was applied. Pico-Salax was administered in two doses, one the evening before and one on the morning of the procedure. PEG-ELS was administered over 4 hours. Efficacy was scored using the Ottawa scale and other constructs. Tolerability and toxicity were measured by patient and nursing questionnaires and serum biochemistry. Results: 35 of Pico-Salax patients (81%) were satisfied or very satisfied with the cleanout, compared with 19 (48%) in the PEG-ELS group (P=0.001). No differences were found in bowel cleanout effectiveness, as judged by the Ottawa score (P=0.24), completion rates (P=0.69), colonoscopy duration (P=0.59), need for enemas (P=0.25), or physicians global impression (P=0.7). Except for one case of mild dehydration in the Pico-Salax group, no clinically significant adverse events were recorded. Serum biochemistry results were similar between groups except for more hypermagnesemia associated with Pico-Salax and hypokalemia with PEG-ELS; neither was clinically significant. Conclusion: Children tolerate Pico-Salax better than PEG-ELS for bowel cleanout before colonoscopy. This study did not demonstrate superiority of effectiveness or safety for either regimen.
UR - https://www.scopus.com/pages/publications/71549127152
U2 - 10.1055/s-0029-1215333
DO - 10.1055/s-0029-1215333
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 19967619
AN - SCOPUS:71549127152
SN - 0013-726X
VL - 41
SP - 1038
EP - 1045
JO - Endoscopy
JF - Endoscopy
IS - 12
ER -